Cincinnati, OH, United States of America

Nat Hemasilpin

This inventor holds 7 USPTO granted patents. Top assignee: Cincinnati Children's Hospital Medical Center. Active years: 1993-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nat Hemasilpin. Retrieved from https://idiyas.com/inventor/nat-hemasilpin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 71.4

Average Co-Inventor Count = 4.7

ph-index = 7

Forward Citations = 867(Granted Patents)


Location History:

  • Fairfield, OH (US) (1993 - 2002)
  • Cincinnati, OH (US) (2004 - 2010)

Company Filing History:


Years Active: 1993-2010

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Nat Hemasilpin

Introduction

Nat Hemasilpin is a prominent inventor based in Cincinnati, OH (US). He has made significant contributions to the field of medical technology, particularly in hemofiltration systems. With a total of 7 patents to his name, Hemasilpin's work focuses on improving patient care through innovative solutions.

Latest Patents

Hemasilpin's latest patents include a hemofiltration system and method based on monitored patient parameters. This multipurpose system is designed for the removal of fluid and soluble waste from a patient's blood. It continuously monitors the flow rates of drained fluid, blood, and infusate. When necessary, the system adjusts the pumping rates to remove a preselected amount of fluid within a specified time frame. A supervisory controller monitors patient parameters, such as heart rate and blood pressure, and adjusts the pumping rates accordingly. The use of fuzzy logic allows the controller to make expert decisions based on a set of supervisory rules. Additionally, an adaptive controller corrects temporal variations in the flow rate based on adaptive and control laws.

Another notable patent is the extracorporeal renal replacement modeling system. This system continuously optimizes the ultrafiltration rate during the renal replacement process by modeling physiological and actual rate data. It maps sensed physiological data to a mathematical model to assess the ultrafiltration rate. The model provides parameters used to predict treatment outcomes based on current conditions. When networked, the system can communicate data using remote and online techniques.

Career Highlights

Hemasilpin is affiliated with Cincinnati Children's Hospital Medical Center, where he applies his expertise in medical technology. His work has significantly impacted patient care and treatment methodologies.

Collaborations

Some of Hemasilpin's notable coworkers include John J Bissler and Yuli Kitaevich. Their collaborative efforts contribute to advancements in medical technology and patient care.

Conclusion

Nat Hemasilpin's innovative contributions to hemofiltration systems and renal replacement processes highlight his commitment to improving healthcare technology. His patents reflect a dedication to enhancing patient outcomes through advanced medical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…